226 related articles for article (PubMed ID: 10749714)
41. Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism.
Dyck JR; Berthiaume LG; Thomas PD; Kantor PF; Barr AJ; Barr R; Singh D; Hopkins TA; Voilley N; Prentki M; Lopaschuk GD
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):599-608. PubMed ID: 10947976
[TBL] [Abstract][Full Text] [Related]
42. Hyperthyroidism facilitates cardiac fatty acid oxidation through altered regulation of cardiac carnitine palmitoyltransferase: studies in vivo and with cardiac myocytes.
Sugden MC; Priestman DA; Orfali KA; Holness MJ
Horm Metab Res; 1999 May; 31(5):300-6. PubMed ID: 10422724
[TBL] [Abstract][Full Text] [Related]
43. Malonyl-CoA and the regulation of fatty acid oxidation in soleus muscle.
Alam N; Saggerson ED
Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):233-41. PubMed ID: 9693125
[TBL] [Abstract][Full Text] [Related]
44. Influence of malonyl-CoA and palmitate concentration on rate of palmitate oxidation in rat muscle.
Merrill GF; Kurth EJ; Rasmussen BB; Winder WW
J Appl Physiol (1985); 1998 Nov; 85(5):1909-14. PubMed ID: 9804598
[TBL] [Abstract][Full Text] [Related]
45. Reduced effects of L-carnitine on glucose and fatty acid metabolism in myocytes isolated from diabetic rats.
Abdel-aleem S; Karim AM; Zarouk WA; Taylor DA; el-Awady MK; Lowe JE
Horm Metab Res; 1997 Sep; 29(9):430-5. PubMed ID: 9370110
[TBL] [Abstract][Full Text] [Related]
46. Regulation of fatty acid oxidation of the heart by MCD and ACC during contractile stimulation.
Goodwin GW; Taegtmeyer H
Am J Physiol; 1999 Oct; 277(4):E772-7. PubMed ID: 10516138
[TBL] [Abstract][Full Text] [Related]
47. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
Velasco G; Geelen MJ; Guzmán M
Arch Biochem Biophys; 1997 Jan; 337(2):169-75. PubMed ID: 9016810
[TBL] [Abstract][Full Text] [Related]
48. Chronic activation of PPARalpha is detrimental to cardiac recovery after ischemia.
Sambandam N; Morabito D; Wagg C; Finck BN; Kelly DP; Lopaschuk GD
Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H87-95. PubMed ID: 16155108
[TBL] [Abstract][Full Text] [Related]
49. Myocardial hypertrophy and the maturation of fatty acid oxidation in the newborn human heart.
Yatscoff MA; Jaswal JS; Grant MR; Greenwood R; Lukat T; Beker DL; Rebeyka IM; Lopaschuk GD
Pediatr Res; 2008 Dec; 64(6):643-7. PubMed ID: 18614968
[TBL] [Abstract][Full Text] [Related]
50. Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats.
Atkinson LL; Kozak R; Kelly SE; Onay Besikci A; Russell JC; Lopaschuk GD
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E923-30. PubMed ID: 12464581
[TBL] [Abstract][Full Text] [Related]
51. Uteroplacental insufficiency down regulates insulin receptor and affects expression of key enzymes of long-chain fatty acid (LCFA) metabolism in skeletal muscle at birth.
Germani D; Puglianiello A; Cianfarani S
Cardiovasc Diabetol; 2008 May; 7():14. PubMed ID: 18485240
[TBL] [Abstract][Full Text] [Related]
52. Activation of AMP-activated protein kinase, inhibition of pyruvate dehydrogenase activity, and redistribution of substrate partitioning mediate the acute insulin-sensitizing effects of troglitazone in skeletal muscle cells.
Fediuc S; Pimenta AS; Gaidhu MP; Ceddia RB
J Cell Physiol; 2008 May; 215(2):392-400. PubMed ID: 17960559
[TBL] [Abstract][Full Text] [Related]
53. Cardiac expression of adiponectin and its receptors in streptozotocin-induced diabetic rats.
Guo Z; Xia Z; Yuen VG; McNeill JH
Metabolism; 2007 Oct; 56(10):1363-71. PubMed ID: 17884446
[TBL] [Abstract][Full Text] [Related]
54. Role of malonyl-CoA in heart disease and the hypothalamic control of obesity.
Folmes CD; Lopaschuk GD
Cardiovasc Res; 2007 Jan; 73(2):278-87. PubMed ID: 17126822
[TBL] [Abstract][Full Text] [Related]
55. The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts.
Onay-Besikci A; Guner S; Arioglu E; Ozakca I; Ozcelikay AT; Altan VM
Can J Physiol Pharmacol; 2007 May; 85(5):527-35. PubMed ID: 17632588
[TBL] [Abstract][Full Text] [Related]
56. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
57. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts.
Saddik M; Lopaschuk GD
J Biol Chem; 1991 May; 266(13):8162-70. PubMed ID: 1902472
[TBL] [Abstract][Full Text] [Related]
58. Calcium regulation of glycolysis, glucose oxidation, and fatty acid oxidation in the aerobic and ischemic heart.
Schönekess BO; Brindley PG; Lopaschuk GD
Can J Physiol Pharmacol; 1995 Nov; 73(11):1632-40. PubMed ID: 8789418
[TBL] [Abstract][Full Text] [Related]
59. Malonyl-CoA decarboxylase is not a substrate of AMP-activated protein kinase in rat fast-twitch skeletal muscle or an islet cell line.
Habinowski SA; Hirshman M; Sakamoto K; Kemp BE; Gould SJ; Goodyear LJ; Witters LA
Arch Biochem Biophys; 2001 Dec; 396(1):71-9. PubMed ID: 11716464
[TBL] [Abstract][Full Text] [Related]
60. Effect of phosphorylation by AMP-activated protein kinase on palmitoyl-CoA inhibition of skeletal muscle acetyl-CoA carboxylase.
Rubink DS; Winder WW
J Appl Physiol (1985); 2005 Apr; 98(4):1221-7. PubMed ID: 15579580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
